Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis
NCT01231854Phase 4Terminated
- Sponsor
- Technische Universität Dresden
- Start
- Nov 2010
- Primary completion
- Mar 2012
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cyclosporine and alitretinoin in atopic dermatitis (AD), sponsored by Technische Universität Dresden. Primary endpoint: Investigator Global Assessment clearance at 24 weeks. Started Nov 2010; status: terminated.
02
Drugs
cyclosporinealitretinoin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01231854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231854.